ARCHIVES

DeVita Era At NCI One Of New Programs, Remarkable Stability

This article is from The Cancer Letter archive.

Vol. 14 No. 34 | August 19, 1988

Download PDF Visit The Full Archive

Related Articles

QOL Of Young Survivors Equal To Other Children

February 25, 2005

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions.

March 9, 2007

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988